QORE Trademark

Trademark Overview

On Monday, March 30, 2009, a trademark application was filed for QORE with the United States Patent and Trademark Office. The USPTO has given the QORE trademark a serial number of 77701817. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 26, 2021. This trademark is owned by BDI Pharma, Inc.. The QORE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Arranging and conducting incentive reward programs to promote the sale of blood derivative products, oncology medicines and medicines
qore

General Information

Serial Number77701817
Word MarkQORE
Filing DateMonday, March 30, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 26, 2021
Registration Number3822824
Registration DateTuesday, July 20, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2009

Trademark Statements

Goods and ServicesArranging and conducting incentive reward programs to promote the sale of blood derivative products, oncology medicines and medicines
Pseudo MarkCORE

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 26, 2021
Primary Code035
First Use Anywhere DateWednesday, April 1, 2009
First Use In Commerce DateWednesday, April 1, 2009

Trademark Owner History

Party NameBDI Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColumbia, SC 29203
Party NameBDI Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbia, SC 29203
Party NameBDI Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbia, SC 29203

Trademark Events

Event DateEvent Description
Friday, February 26, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, July 20, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 1, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, August 1, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, July 31, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 19, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 20, 2010REGISTERED-PRINCIPAL REGISTER
Saturday, June 12, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, June 11, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 11, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 14, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 18, 2010USE AMENDMENT FILED
Tuesday, April 13, 2010EXTENSION 1 GRANTED
Thursday, March 18, 2010EXTENSION 1 FILED
Monday, April 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 18, 2010TEAS EXTENSION RECEIVED
Thursday, March 18, 2010TEAS STATEMENT OF USE RECEIVED
Monday, October 26, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 26, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 20, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2009NOTICE OF PUBLICATION
Tuesday, June 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 23, 2009ASSIGNED TO LIE
Thursday, June 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 18, 2009ASSIGNED TO EXAMINER
Friday, April 3, 2009NOTICE OF PSEUDO MARK MAILED
Thursday, April 2, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 2, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

qore medicines blood derivative oncology sale products promote conducting incentive reward